Icosahydrodibenzo[B,K][1,4,7,10,13,16]Hexaoxacyclooctadecine

Icosahydrodibenzo[B,K][1,4,7,10,13,16]Hexaoxacyclooctadecine

SCHEMBL35551

C1CCC2OCCOCCOC3CCCCC3OCCOCCOC2C1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.38
ALDH1A1 P00352 1/20 0.33
PDK1 Q15118 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5067399 1.00 TTR (0.38) TTRALDH1A1PDK1CHRM2CHRM4
SCHEMBL14156075 1.00 TTR (0.38) TTRALDH1A1PDK1CHRM2CHRM4
SCHEMBL14488913 1.00 TTR (0.38) TTRALDH1A1PDK1CHRM2CHRM4
SCHEMBL14488843 1.00 TTR (0.38) TTRALDH1A1PDK1CHRM2CHRM4
SCHEMBL5027573 1.00 TTR (0.38) TTRALDH1A1PDK1CHRM2CHRM4
Icosahydrodibenzo[B,K][1,4,7,10,13,16]Hexaoxacyclooctadecine SCHEMBL23646852 1.00 TTR (0.38) TTRALDH1A1PDK1CHRM2CHRM4
SCHEMBL12533535 1.00 TTR (0.38) TTRALDH1A1PDK1CHRM2CHRM4
SCHEMBL19766264 1.00 TTR (0.38) TTRALDH1A1PDK1CHRM2CHRM4
Icosahydrodibenzo[B,K][1,4,7,10,13,16]Hexaoxacyclooctadecine SCHEMBL9770208 0.94 TTR (0.33) TTRALDH1A1PDK1CHRM2CHRM4
SCHEMBL10919024 0.92 ALDH1A1 (0.42) TTRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1556 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747611-A1 OPTICAL ELECTRODE ANALYTE DETECTION SYSTEM AND METHODS OF USE Vital Biosciences Inc. (CA) 2026-05-27 EP claimed
US-20260142234-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CROWN ETHER BASED COMPOUNDS ENEVATE CORP (US) 2026-05-21 US claimed
US-12308133-B2 Method for producing lead-212 from an aqueous solution comprising thorium-228 and daughters thereof ORANO MED (FR) 2025-05-20 US claimed
EP-3700951-B1 CYANOACRYLATE COMPOSITIONS HENKEL AG & CO KGAA (DE) 2025-04-23 EP claimed
EP-3371268-B1 CYANOACRYLATE COMPOSITIONS HENKEL AG & CO KGAA (DE) 2025-04-02 EP claimed
CN-119707750-A Preparation method of hydrocarbyl sulfonyl chloride and method for co-producing hydrocarbyl sulfonyl chloride and difluorophosphate 深圳市研一新材料有限责任公司 2025-03-28 CN claimed
CN-119581669-A Electrolyte, lithium ion battery and electric equipment 浙江锂威能源科技有限公司 2025-03-07 CN claimed
WO-2025022286-A1 OPTICAL ELECTRODE ANALYTE DETECTION SYSTEM AND METHODS OF USE VITAL BIOSCIENCES INC. (CA) 2025-01-30 WO claimed
CN-119330833-A Synthesis method of 2, 4-difluoronitrobenzene 河北君瑞沣新材料有限公司 2025-01-21 CN claimed
CN-119263977-A Preparation method of perfluoro-2-alkoxypropionyl fluoride and perfluoroalkyl vinyl ether 河南省氟基新材料科技有限公司 2025-01-07 CN claimed
US-4352726-A HAVING A POLYMER MADE FROM A GIANT HETEROCYCLIC COMPOUND TAKASHI MUKAIBO (JP) 1982-10-05 US claimed
US-4333860-A COMPLEXING, IMPREGNATION PHILLIPS PETROLEUM COMPANY (US) 1982-06-08 US claimed
EP-0000219-B1 MACROCYCLIC POLYETHER COMPLEXES AND A PROCESS FOR THE ISOLATION OF MACROCYCLIC POLYETHERS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1981-09-23 EP claimed
US-4278814-A Preparation of 2-methylene-1,3-propanediamide by a fluoride anion-initiated β-elimination reaction POLAROID CORPORATION (US) 1981-07-14 US claimed
US-4239914-A Process for preparing 2-(6'-methoxy-2'-naphthyl)-propionic acid MONTEDISON S.P.A. (IT) 1980-12-16 US claimed
US-4186175-A USE TO SEPARATE URANYL HALIDES FROM NICKEL HALIDES AND COPPER HALIDES, PHOTOCHEMICAL REACTION WITH WATER AND CARBOXYLATE ION TO PRODUCE URANIUM OXIDE HYDRATE PHILLIPS PETROLEUM COMPANY (US) 1980-01-29 US claimed
US-4158616-A PHOTOCHEMICAL OXIDATION, CROWN ETHERS PHILLIPS PETROLEUM COMPANY (US) 1979-06-19 US claimed
US-4057591-A FLUORIDE AND CROWN ETHER AS CATALYST CENTRAL GLASS COMPANY, LIMITED (JA) 1977-11-08 US claimed
US-4042638-A IN PRESENCE OF ALKALI METAL HALIDE AND A CROWN ETHER CENTRAL GLASS CO., LTD. (JA) 1977-08-16 US claimed
US-3998838-A CURING COMPOUNDS; VULCANIZATION E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-12-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260142234-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CROWN ETHER BASED COMPOUNDS SLC8A1, RPS4X, LBR TTR 3833/4885ALDH1A1 3457/4885PDK1 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.